fludarabine has been researched along with Carcinoma, Hepatocellular in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Dong, J; Meng, G; Wei, J; Wu, J; Zhang, H; Zhang, Y; Zuo, S | 1 |
Chen, L; Chen, M; Chen, W; Zhang, B; Zhang, L; Zhang, Y | 1 |
Boyer, SH; Erion, MD; Linemeyer, DL; MacKenna, DA; Montag, A | 1 |
Bi, X; Fang, J; Meng, D; Wu, G; Xue, J | 1 |
Gati, WP; Kieller, DM; Rahn, JJ; Tyrrell, DL | 1 |
5 other study(ies) available for fludarabine and Carcinoma, Hepatocellular
Article | Year |
---|---|
Recombinant adenovirus expressing the fusion protein PD1PVR improves CD8
Topics: Adenoviridae; Animals; Antineoplastic Agents; Ascites; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Disease Models, Animal; Immunologic Surveillance; Immunosuppression Therapy; Inflammation; Liver Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Male; Mice, Inbred C57BL; Oncolytic Viruses; Recombinant Fusion Proteins; Treatment Outcome; Vidarabine; Virus Replication | 2021 |
An ultrasonic nanobubble-mediated PNP/fludarabine suicide gene system: A new approach for the treatment of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Gene Transfer Techniques; Genes, Transgenic, Suicide; Green Fluorescent Proteins; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Nanostructures; Purine-Nucleoside Phosphorylase; Ultrasonics; Vidarabine | 2018 |
Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Cytarabine; Cytochrome P-450 CYP3A; Drug Delivery Systems; Infusions, Intravenous; Liver; Liver Neoplasms; Male; Mice; Nucleosides; Prodrugs; Thymidine; Tissue Distribution; Vidarabine | 2009 |
Fludarabine reduces survivability of HepG2 cells through VEGF under hypoxia.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Oxygen; Vascular Endothelial Growth Factor A; Vidarabine | 2007 |
Modulation of the metabolism of beta-L-(-)-2',3'-dideoxy-3'-thiacytidine by thymidine, fludarabine, and nitrobenzylthioinosine.
Topics: Affinity Labels; Animals; Anti-HIV Agents; Antineoplastic Agents; Carcinoma, Hepatocellular; Cells, Cultured; Drug Interactions; Ducks; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Humans; Thioinosine; Thymidine; Tumor Cells, Cultured; Vidarabine; Zalcitabine | 1997 |